Ebola, fake drugs and other 21st century challenges for health regulators
Introduction:
How do you go about making it possible to use an unlicensed vaccine to combat the deadly Ebola disease?
That’s just one of the tasks facing global health regulators, who’ve had their work cut out this week in discussions on everything from the Ebola outbreak in the Democratic Republic of the Congo (DRC) to tackling the worldwide spread of fake drugs.
Speaking to UN News, Dr. Emer Cooke from the World Health Organization (WHO) explains to Michelle Kusuma how regulators play a vital role in strengthening global collaboration - and ensuring patient safety.
Global health regulators met this week in Geneva to discuss everything from the Ebola outbreak in the Democratic Republic of the Congo (DRC) to tackling the worldwide spread of fake drugs.
Dr. Emer Cooke, Head of the Regulation of Medicines and other Health Technologies (RHT) Unit, at the World Health Organization (WHO), spoke with UN News’s Michelle Kusuma.
Dr. Cooke explained how regulators play a vital role in strengthening global collaboration - and ensuring patient safety.